Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

[Unresectable colorectal liver metastases : Prolonged survival with aggressive local therapy].

Strobel O, Büchler MW.

Chirurg. 2019 Mar;90(Suppl 2):81. doi: 10.1007/s00104-019-0854-z. German. No abstract available.

PMID:
30758571
2.

[Unresectable colorectal liver metastases : Prolonged survival with aggressive local therapy].

Strobel O, Büchler MW.

Chirurg. 2017 Sep;88(9):803. doi: 10.1007/s00104-017-0486-0. German. No abstract available.

PMID:
28741171
3.

Long-term survival of patients with unresectable colorectal liver metastases treated by percutaneous interstitial laser thermotherapy.

Christophi C, Nikfarjam M, Malcontenti-Wilson C, Muralidharan V.

World J Surg. 2004 Oct;28(10):987-94. Epub 2004 Sep 29.

PMID:
15573253
4.

Cryosurgery for resectable and unresectable hepatic metastases from colorectal cancer.

Bageacu S, Kaczmarek D, Lacroix M, Dubois J, Forest J, Porcheron J.

Eur J Surg Oncol. 2007 Jun;33(5):590-6. Epub 2007 Feb 26.

PMID:
17321714
5.

Liver transplantation in a patient with unresectable colorectal liver metastases -- a case report.

Hrehoreţ D, Alexandrescu S, Braşoveanu V, Grigorie R, Zielinski C, Popescu I.

Chirurgia (Bucur). 2013 Sep-Oct;108(5):719-24.

6.

Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial.

Ruers T, Van Coevorden F, Punt CJ, Pierie JE, Borel-Rinkes I, Ledermann JA, Poston G, Bechstein W, Lentz MA, Mauer M, Folprecht G, Van Cutsem E, Ducreux M, Nordlinger B; European Organisation for Research and Treatment of Cancer (EORTC); Gastro-Intestinal Tract Cancer Group; Arbeitsgruppe Lebermetastasen und tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); National Cancer Research Institute Colorectal Clinical Study Group (NCRI CCSG).

J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx015.

7.

Treatment of liver metastases, an update on the possibilities and results.

Ruers T, Bleichrodt RP.

Eur J Cancer. 2002 May;38(7):1023-33. Review.

PMID:
11978527
8.

Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).

Collettini F, Lutter A, Schnapauff D, Hildebrandt B, Puhl G, Denecke T, Wust P, Gebauer B.

Rofo. 2014 Jun;186(6):606-12. doi: 10.1055/s-0033-1355887. Epub 2014 Jan 9.

9.

New Perspectives in the Treatment of Colorectal Metastases.

Elias D, Viganò L, Orsi F, Scorsetti M, Comito T, Lerut J, Cosola D, Torzilli G.

Liver Cancer. 2016 Nov;6(1):90-98. Epub 2016 Nov 29. Review.

10.

Survival after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced colorectal liver metastases: A case-matched comparison with palliative systemic therapy.

Olthof PB, Huiskens J, Wicherts DA, Huespe PE, Ardiles V, Robles-Campos R, Adam R, Linecker M, Clavien PA, Koopman M, Verhoef C, Punt CJ, van Gulik TM, de Santibanes E.

Surgery. 2017 Apr;161(4):909-919. doi: 10.1016/j.surg.2016.10.032. Epub 2016 Dec 27.

PMID:
28038862
11.

Single-institution experience with selective internal radiation therapy (SIRT) for the treatment of unresectable colorectal liver metastases.

O'Leary C, Greally M, McCaffrey J, Hughes P, Lawler LLP, O'Connell M, Geoghegan T, Farrelly C.

Ir J Med Sci. 2019 Feb;188(1):43-53. doi: 10.1007/s11845-018-1773-6. Epub 2018 Mar 6.

PMID:
29511912
12.

Neoadjuvant and adjuvant therapy in relation to surgery for colorectal liver metastases.

Brouquet A, Nordlinger B.

Scand J Gastroenterol. 2012 Mar;47(3):286-95. doi: 10.3109/00365521.2012.640826. Epub 2011 Dec 19. Review.

PMID:
22182353
13.

Prediction of survival in patients with unresectable colorectal liver metastases.

Hołówko W, Grąt M, Hinderer B, Orlińska I, Krawczyk M.

Pol Przegl Chir. 2014 Jul;86(7):319-24. doi: 10.2478/pjs-2014-0056.

PMID:
25222579
14.

Current treatment options for patients with initially unresectable isolated colorectal liver metastases.

Kanat O.

World J Clin Oncol. 2016 Feb 10;7(1):9-14. doi: 10.5306/wjco.v7.i1.9.

15.

Multivariate analysis of the prognostic factors of patients with unresectable synchronous liver metastases from colorectal cancer.

Yamamura T, Tsukikawa S, Akaishi O, Tanaka K, Matsuoka H, Hanai A, Oikawa H, Ozasa T, Kikuchi K, Matsuzaki H, Yamaguchi S.

Dis Colon Rectum. 1997 Dec;40(12):1425-9.

PMID:
9407979
16.

Strategies to treat primary unresectable colorectal liver metastases.

Vibert E, Canedo L, Adam R.

Semin Oncol. 2005 Dec;32(6 Suppl 8):33-9. Review.

PMID:
16360011
17.

Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial.

Gruenberger T, Bridgewater J, Chau I, García Alfonso P, Rivoire M, Mudan S, Lasserre S, Hermann F, Waterkamp D, Adam R.

Ann Oncol. 2015 Apr;26(4):702-8. doi: 10.1093/annonc/mdu580. Epub 2014 Dec 23.

PMID:
25538173
18.

Determinants of unresectability and outcome of patients with occult colorectal hepatic metastases.

Bennett JJ, Cao D, Posner MC.

J Surg Oncol. 2005 Oct 1;92(1):64-9.

PMID:
16180230
19.

Transpleurodiaphragmatic cryosurgical ablation for recurrent unresectable colorectal liver metastases.

Stella M, Mithieux F, Meeus P, Kaemmerlen P, Lafon C, Rivoire M.

J Surg Oncol. 2006 Mar 15;93(4):268-72.

PMID:
16496368
20.

Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases.

Goéré D, Deshaies I, de Baere T, Boige V, Malka D, Dumont F, Dromain C, Ducreux M, Elias D.

Ann Surg. 2010 Apr;251(4):686-91. doi: 10.1097/SLA.0b013e3181d35983.

PMID:
20224373

Supplemental Content

Support Center